Northstar Hearing Center | |
203 N 8th Ave E, Duluth, MN 55805-3254 | |
(218) 724-3477 | |
Not Available |
Full Name | Northstar Hearing Center |
---|---|
Type | Facility |
Speciality | Hearing Instrument Specialist |
Location | 203 N 8th Ave E, Duluth, Minnesota |
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1093856718 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Northstar Hearing Center 203 N 8th Ave E, Duluth, MN 55805-3254 Ph: (218) 724-3477 | Northstar Hearing Center 203 N 8th Ave E, Duluth, MN 55805-3254 Ph: (218) 724-3477 |
News Archive
Recently published UT Southwestern research reveals new insights about risk factors for depression based on data from a landmark longitudinal study focused on heart disease.
Among African-Americans with prostate cancer, a tumor-suppressing gene called GSTP1 is inactivated at a rate 3.5 times higher than among Caucasians, according to a study conducted at the San Francisco VA Medical Center (SFVAMC).
We Americans are rightfully proud of our can-do spirit. We know that our nation is capable of uniting for a common goal -; and triumphing. In this time of economic challenge and political divisiveness, we are proposing an idea for our country's next common mission: biomedical innovation. From our combined decades of experience leading in the Congress and the U.S. Department of Health and Human Services, we see the biomedical frontier as America's greatest opportunity to align our nation's competencies and resources for a better future.
Sosei Group Corporation confirms the information released today by Novartis that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Seebri Breezhaler (glycopyrronium/NVA237) 44 mcg delivered dose (50 mcg glycopyrronium per capsule), as a once-daily inhaled maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
The future of pediatric and perinatal palliative care should include accepting parents' need for proximity to the child, combining the strategies of palliative and intensive care physicians, improving healthcare providers' listening skills, and involving multiple disciplines, recommend researchers.
› Verified 9 days ago